Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Caseshaematology-oncology-and-transfusion

Paeds Cases · haematology-oncology-and-transfusion

Haematopoietic stem-cell transplantation: Case

Clinical long case of a six-year-old boy with relapsed B-cell precursor acute lymphoblastic leukaemia undergoing an allogeneic haematopoietic stem-cell transplant, covering the donor selection, the conditioning, the graft-versus-host prophylaxis, the engraftment, the acute graft-versus-host disease, the sinusoidal obstruction syndrome, the febrile neutropenia, the donor chimerism and the family counselling.

paediatric haematology long case3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A six-year-old boy is admitted for an allogeneic haematopoietic stem-cell transplant for a second remission relapsed B-cell precursor acute lymphoblastic leukaemia. He has no matched sibling, and a matched unrelated donor has been identified through the international registry. He underwent the myeloablative conditioning with the total body irradiation and the etoposide, and the peripheral blood stem cells were infused on day zero. He is now on day fourteen, with the mucositis and the cytopenia, a tender liver palpable three centimetres below the costal margin, a weight gain of eight percent from the baseline, and a bilirubin that has risen from normal to sixty-two micromoles per litre. The examiner asks how you frame the problem, how you distinguish the sinusoidal obstruction syndrome from the graft-versus-host disease and the drug injury, how you confirm and treat the hepatic complication, and how you counsel the family on the course and the late effects.

Framing the case

This six-year-old boy is on day fourteen of an allogeneic matched unrelated donor transplant, with the weight gain, the tender hepatomegaly and the rising bilirubin that together point to the hepatic sinusoidal obstruction syndrome. The timing, within the first twenty-one days of the myeloablative conditioning, the total body irradiation and the etoposide, is the classic window for the syndrome, and the weight gain of eight percent from the baseline alongside the tender liver and the jaundice meets the diagnostic triad. The framework is the recognition that this is a hepatotoxic complication of the conditioning, distinct from the graft-versus-host disease and the drug injury, and that the early recognition and the prompt defibrotide are the decisive interventions. [8]

The differential and the diagnostic pathway

The hepatic differential at this point is the sinusoidal obstruction syndrome against the hepatic graft-versus-host disease, the drug-induced liver injury from the antifungal or the antibiotic, and the viral hepatitis. The sinusoidal obstruction syndrome presents early, within the first twenty-one days, with the weight gain and the tender liver, while the hepatic graft-versus-host presents later, often after the engraftment, with the jaundice and the gut involvement. The diagnosis of the sinusoidal obstruction syndrome is clinical, supported by the ultrasound with the doppler showing the reversal of the portal flow and the elevated hepatic pressures, with the transjugular liver biopsy and the pressure measurement in the selected case. The viral studies exclude the cytomegalovirus and the hepatitis, and the drug history excludes the reaction. [8][1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Kanate AS, Majhail NS, Savani BN Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy Biol Blood Marrow Transplant, 2020.PMID 32165328
  2. [4]Bolaños-Meade J, Hamadani M, Wu J Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis N Engl J Med, 2023.PMID 37342922
  3. [8]Mohty M, Malard F, Alaskar AS Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European Society for Blood and Marrow Transplantation Bone Marrow Transplant, 2023.PMID 37095231
  4. [10]Aziz MT, Kakadiya PP, Kush SM Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome Ann Pharmacother, 2018.PMID 28914546
  5. [11]Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation Transplant Cell Ther, 2021.PMID 34304802
  6. [12]Lehrnbecher T, Robinson P, Fisher B Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update J Clin Oncol, 2017.PMID 28459614
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousGerm-cell tumours: Casehaematology-oncology-and-transfusionNextHaemolytic anaemia: diagnostic approach: Casehaematology-oncology-and-transfusion